Home > Boards > US Listed > Biotechs > PharmaCyte Biotech Inc. (PMCB)

I own no shares, Im watching it closely,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
richboy1 Member Profile
 
Followed By 373
Posts 28,299
Boards Moderated 2
Alias Born 06/16/07
160x600 placeholder
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation Business Wire - 11/12/2021 9:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/8/2021 6:01:27 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 11/4/2021 7:39:35 AM
PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA Business Wire - 9/27/2021 9:00:00 AM
PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests Business Wire - 9/21/2021 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/14/2021 8:02:08 AM
PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/8/2021 9:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/3/2021 7:20:53 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/1/2021 6:04:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:25:24 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:23 PM
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study Business Wire - 8/31/2021 9:20:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/30/2021 8:31:26 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/30/2021 6:31:47 AM
PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise Business Wire - 8/25/2021 9:00:00 AM
PharmaCyte Biotech Announces Closing of $70 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Business Wire - 8/23/2021 4:39:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/23/2021 6:09:01 AM
Big movements in Pharmacyt Biotch stock price on Thursday moving 28.36% between high and low StockInvest.us - 8/19/2021 8:10:18 PM
richboy1   Thursday, 09/10/15 08:58:50 AM
Re: frosr6 post# 40291
Post # of 144070 
I own no shares, Im watching it closely, I think theres a buyout chance here. keep it on my radar and i'll carry on.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences